Novel Biomarker Discovery Could Lead to Early Diagnosis of Preeclampsia
The discovery of two novel biomarkers—FKBPL and CD44—has the potential to change the way preeclampsia is managed.
Read MorePosted by Laurie Bonner | Jul 5, 2020 | Prenatal Testing |
The discovery of two novel biomarkers—FKBPL and CD44—has the potential to change the way preeclampsia is managed.
Read MorePosted by Laurie Bonner | Jul 4, 2020 | Diabetes & Metabolic Diseases |
Repeated measurements of the biomarker FIB-4 in the blood every few years can predict the risk of developing severe liver disease.
Read MorePosted by Laurie Bonner | Jul 2, 2020 | Diabetes & Metabolic Diseases, Microbiology |
Stool microbes make a challenging diagnosis easier.
Read MorePosted by Laurie Bonner | Jun 22, 2020 | Uncategorized |
KidneyIntelX can identify patients at the highest risk of progressive decline in kidney function in early stage diabetic kidney disease.
Read MorePosted by Laurie Bonner | Jun 12, 2020 | Uncategorized |
A specific viral exposure signature that could accurately distinguish people with HCC from those with chronic liver disease and healthy volunteers.
Read More